Juliet Thompson serves as Executive at Indivior Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Juliet Thompson has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 26, 2026 involved receiving (via award) 3,722 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jan 26, 2026 | INDV | $0 | Award | 3,722 | $N/A | Discretionary |
Juliet Thompson currently holds 7,572 shares of Indivior Pharmaceuticals, Inc. (INDV), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Juliet Thompson has been a net neutral trader of INDV stock. They have purchased $0 and sold $0 worth of shares.
Juliet Thompson's most recent insider trade was on Jan 26, 2026, when they sold 3,722 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted